Cargando…

Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes

A complete eradication of an HIV infection has never been achieved by vaccination and the search for new immunogens that can induce long-lasting protective responses is ongoing. Avipoxvirus recombinants are host-restricted for replication to avian species and they do not have the undesired side effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bissa, Massimiliano, Forlani, Greta, Zanotto, Carlo, Tosi, Giovanna, De Giuli Morghen, Carlo, Accolla, Roberto S., Radaelli, Antonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791965/ https://www.ncbi.nlm.nih.gov/pubmed/29385169 http://dx.doi.org/10.1371/journal.pone.0190869

Ejemplares similares

Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein
por: Zanotto, Carlo, et al.
Publicado: (2011)

L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines
por: Pacchioni, Sole Maria, et al.
Publicado: (2013)

Protection of mice against the highly pathogenic VV(IHD-J) by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity
por: Bissa, Massimiliano, et al.
Publicado: (2016)

The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1
por: Forlani, Greta, et al.
Publicado: (2015)

Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain
por: Bissa, Massimiliano, et al.
Publicado: (2013)

The MHC Class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation
por: Abdallah, Rawan, et al.
Publicado: (2014)

Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits
por: Radaelli, Antonia, et al.
Publicado: (2010)

A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers
por: Bissa, Massimiliano, et al.
Publicado: (2015)

The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells
por: Forlani, Greta, et al.
Publicado: (2016)

Construction of a recombinant avipoxvirus expressing the env gene of Zika virus as a novel putative preventive vaccine
por: Zanotto, Carlo, et al.
Publicado: (2021)

MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to, and affecting Tax-2 intracellular localization
por: Orlandi, Chiara, et al.
Publicado: (2011)

The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators
por: Forlani, Greta, et al.
Publicado: (2013)

The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T-Cell Lymphotropic Virus Type 1
por: Tosi, Giovanna, et al.
Publicado: (2011)

CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
por: Accolla, Roberto S., et al.
Publicado: (2019)

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA
por: Celesti, Fabrizio, et al.
Publicado: (2023)

Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication
por: Orlandi, Chiara, et al.
Publicado: (2011)

Unveiling the Hidden Treasury: CIITA-Driven MHC Class II Expression in Tumor Cells to Dig up the Relevant Repertoire of Tumor Antigens for Optimal Stimulation of Tumor Specific CD4+ T Helper Cells
por: Forlani, Greta, et al.
Publicado: (2020)

The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy
por: Forlani, Greta, et al.
Publicado: (2023)

Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1
por: Forlani, Greta, et al.
Publicado: (2019)

Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques
por: Valentin, Antonio, et al.
Publicado: (2015)

A dual defensive role of CIITA against retroviral infections
por: Tosi, Giovanna, et al.
Publicado: (2006)

Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
por: Raval, Goutham U, et al.
Publicado: (2015)

Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
por: Raval, Goutham U, et al.
Publicado: (2015)

Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
por: Raval, Goutham U, et al.
Publicado: (2015)

CIITA and Its Dual Roles in MHC Gene Transcription
por: Devaiah, Ballachanda N., et al.
Publicado: (2013)

CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens
por: Forlani, Greta, et al.
Publicado: (2021)

Boosting the MHC Class II-Restricted Tumor Antigen Presentation to CD4+ T Helper Cells: A Critical Issue for Triggering Protective Immunity and Re-Orienting the Tumor Microenvironment Toward an Anti-Tumor State
por: Accolla, Roberto S., et al.
Publicado: (2014)

SIRT1 links CIITA deacetylation to MHC II activation
por: Wu, Xiaoyan, et al.
Publicado: (2011)

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques
por: Li, Hongzhao, et al.
Publicado: (2018)

Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8(+) T cells but not CD4(+) T cells
por: Ishii, Hiroshi, et al.
Publicado: (2022)

Endogenous retrovirus type W GAG and ENV antigenaemia in serum of schizophrenic patients
por: Bernard, Corinne, et al.
Publicado: (2009)

Class II Transactivator (CIITA) Enhances Cytoplasmic Processing of HIV-1 Pr55Gag
por: Porter, Kristen A., et al.
Publicado: (2010)

Rapid detection of vaccinia virus using biofunctionalized fiber-optic ball-tip biosensors
por: Rakhimbekova, Aida, et al.
Publicado: (2023)

Benzamide Derivatives Targeting the Cell Division Protein FtsZ: Modifications of the Linker and the Benzodioxane Scaffold and Their Effects on Antimicrobial Activity
por: Straniero, Valentina, et al.
Publicado: (2020)

Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice
por: Andersson, Anne-Marie Carola, et al.
Publicado: (2016)

Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses
por: Forlani, Greta, et al.
Publicado: (2017)

Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: implications for HPV-tumor diagnosis and therapy
por: Illiano, Elena, et al.
Publicado: (2016)

Coordinated changes of HIV-1 Gag and Env during assembly and maturation
por: Kräusslich, Hans-Georg
Publicado: (2013)

NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity
por: Santharam, Madanraj Appiya, et al.
Publicado: (2023)

Fragmentation of SIV-gag Vaccine Induces Broader T Cell Responses
por: Benlahrech, Adel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_shme921298t9cl0gu2j7gojmnu